MULLENNIX STEPHEN (COO) sold 10.2% of their position (608.00 shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $23.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/16/2019ACC: 0001209191-19-030594
-608.00
Net shares
Net seller
$23.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.76K acquired · 2.37K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+1.76K
Price / share
—
Trade value
—
% of position
41.6%
5/14/2019
4.23K→5.99K
Ordinary Shares
Direct
Shares
−608.00
Price / share
$37.98
Trade value
$23.09K
% of position
10.2%
5/14/2019
5.99K→5.38K
Total
Net shares
+1.15K
Net value
-$23.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 5/14/2019 | M · Option Exercise | +1.76K | — | — | 41.6% | 4.23K | 5.99K |
| Ordinary Shares Direct | 5/14/2019 | S · Sale | −608.00 | $37.98 | $23.09K | 10.2% | 5.99K | 5.38K |
| Total | +1.15K | -$23.09K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Ordinary Shares
1.76K shares
Shares
−1.76K
Strike price
Held after
12.31K
Exercisable
—
5/14/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Ordinary Shares1.76K shares | 5/14/2019 | M · Option Exercise | −1.76K | — | 12.31K |